0000899243-21-034290.txt : 20210826 0000899243-21-034290.hdr.sgml : 20210826 20210826171443 ACCESSION NUMBER: 0000899243-21-034290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210817 FILED AS OF DATE: 20210826 DATE AS OF CHANGE: 20210826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ellis Andrea CENTRAL INDEX KEY: 0001877680 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 211213274 MAIL ADDRESS: STREET 1: C/O BRIDGEBIO PHARMA, INC. STREET 2: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-17 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001877680 Ellis Andrea C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 0 0 0 Stock Option (right to buy) 49.54 2021-08-17 4 A 0 49869 0.00 A 2031-08-16 Common Stock 49869 49869 D The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date. /s/ Barbara Bispham, Attorney-in-Fact 2021-08-26